GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Pfizer Inc.
Pfizer became a household name during the pandemic thanks to its COVID-19 vaccine. The company's stock price reflects its transition from this success to other areas, such as oncology and rare diseases, as well as its ability to expand its portfolio with new drugs.
Share prices of companies in the market segment - Pharma holding
Pfizer is a global pharmaceutical giant with segments in oncology, vaccines, hospital drugs, and rare disease treatment. We classify it as part of the Pharma Holdings sector, and the chart below shows the overall performance of the entire large drug manufacturing industry.
Broad Market Index - GURU.Markets
Pfizer is one of the world's largest pharmaceutical giants, with a diversified portfolio of vaccines and drugs. Its massive market capitalization makes it a pillar of the GURU.Markets index. The chart below represents the entire market. Find out how Pfizer shares compare to the broader market.
Change in the price of a company, segment, and market as a whole per day
PFE - Daily change in the company's share price Pfizer Inc.
Daily price changes for pharmaceutical giant Pfizer are a measure of its response to the success of new drugs and global healthcare events. While the graph of these fluctuations is unspectacular, it is an important component of the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma holding
Pfizer Inc. is one of the world's largest pharmaceutical giants. This chart shows the average daily volatility of the entire industry. Comparing it to the PFE trend helps understand how a diversified portfolio of drugs and vaccines makes the company more or less exposed to industry risks.
Daily change in the price of a broad market stock, index - GURU.Markets
Pfizer is one of the world's largest pharmaceutical giants. The pharmaceutical sector can be defensive, but breakthroughs and setbacks in drug development create their own volatility. The chart below shows overall market dynamics, allowing you to assess how Pfizer fits into the global landscape.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Pfizer Inc.
Pfizer has undergone a transformation over the past year following the COVID-19 pandemic, focusing on its portfolio of oncology and other drugs. Its stock price has reflected this complex transformation and the company's efforts to find new sources of growth.
Annual dynamics of market capitalization of the market segment - Pharma holding
Pfizer Inc. has become known worldwide for its COVID-19 vaccine. Now the company faces the challenge of proving that it can grow without pandemic demand, thanks to its broad portfolio of drugs. The chart will show whether investors believe in its long-term strategy and new product line.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Pfizer is a global pharmaceutical giant whose performance in recent years has been closely tied to the success of its COVID-19 vaccine and treatments. Investors are now assessing the company's ability to replace these revenues with new products. Comparisons with the market will show how the company transitions from the pandemic boom to sustainable growth based on its broad portfolio.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Pfizer Inc.
Pfizer's monthly price fluctuations reflect the life cycle of its pharmaceutical products. In recent years, the chart's dynamics have been driven by sales of its COVID-19 vaccine and treatments, but are now shifting toward the success of its core drug portfolio and new developments in oncology and other areas.
Monthly dynamics of market capitalization of the market segment - Pharma holding
Here you can see the dynamics of the entire pharmaceutical sector, which experienced an unprecedented boom during the pandemic and then faced its consequences. For Pfizer, one of the leaders in that race, this chart is the backdrop. It shows how the entire industry sought new growth drivers after demand for COVID-19 vaccines declined.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Pfizer is a global pharmaceutical giant whose products are in demand regardless of economic cycles. This makes the company a classic "defensive" asset. The chart below illustrates general market fluctuations. By comparing Pfizer's performance to it, one can see whether the company's shares truly perform more reliably during periods of market turbulence.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Pfizer Inc.
Pfizer Inc., one of the global pharmaceutical giants, is seeking new growth opportunities following the success of its COVID-19 vaccine. Its weekly stock price is driven by news on sales of existing drugs, clinical trial results, and strategic acquisitions, reflecting investor assessments of its future prospects.
Weekly dynamics of market capitalization of the market segment - Pharma holding
As one of the world's largest pharmaceutical giants, Pfizer is an important barometer for the entire sector. Its performance often aligns with industry trends. However, since the pandemic, investors are comparing its ability to find new blockbusters with its competitors. This chart shows whether it is maintaining its lead in the innovation race.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Pfizer, one of the global pharmaceutical giants, is searching for new growth drivers after the COVID-19 pandemic subsides. The market is assessing the prospects of its new drugs. The chart shows how this period of uncertainty affects its stock price compared to a stable market.
Market capitalization of the company, segment and market as a whole
PFE - Market capitalization of the company Pfizer Inc.
Pfizer's market capitalization chart is a clear example of how the market reacts to the creation of a blockbuster. Its surge during the pandemic was directly linked to the development of a COVID-19 vaccine in collaboration with BioNTech. The dynamics since this peak demonstrate how investors assess the company's ability to offset the decline in demand for the vaccine with other drugs.
PFE - Share of the company's market capitalization Pfizer Inc. within the market segment - Pharma holding
Pfizer is one of the world's largest pharmaceutical giants. Its market share has skyrocketed thanks to the success of its COVID-19 vaccine, demonstrating its scientific prowess and manufacturing capabilities. Its market capitalization reflects its broad drug portfolio and ability to innovate rapidly.
Market capitalization of the market segment - Pharma holding
The chart below shows the trillion-dollar value of the global pharmaceutical industry. Pfizer, especially following the success of its COVID-19 vaccine, has cemented its status as one of its titans. The dynamics of this market reflect both the constant need for new drugs and the ability of giants like Pfizer to quickly respond to global health crises.
Market capitalization of all companies included in a broad market index - GURU.Markets
Pfizer is one of the world's largest pharmaceutical giants, becoming a household name during the pandemic. Its market capitalization reflects its ability to quickly develop and bring blockbuster drugs to market. The chart below shows the scale of Big Pharma's influence on the global economy.
Book value capitalization of the company, segment and market as a whole
PFE - Book value capitalization of the company Pfizer Inc.
Pfizer's foundation is its global network of R&D centers and massive manufacturing capacity, which, for example, has enabled it to produce billions of doses of its COVID-19 vaccine. Its book value reflects this scale. The chart below is a financial timeline of the life cycles of its drugs: from their rise on the wave of blockbusters to the search for new sources of growth after patents expire.
PFE - Share of the company's book capitalization Pfizer Inc. within the market segment - Pharma holding
Palo Alto Networks is a leader in cybersecurity, and to combat threats, the company is building a global physical infrastructure. The chart shows its share of real assets—secure data centers and analytics centers that process trillions of security events in real time.
Market segment balance sheet capitalization - Pharma holding
Pfizer is a global pharmaceutical giant. The sector's asset chart confirms that it is a capital-intensive industry. Pfizer owns one of the world's largest networks of factories and R&D centers, allowing it to simultaneously develop and produce billions of doses of drugs and vaccines.
Book value of all companies included in the broad market index - GURU.Markets
Pfizer Inc. is one of the world's largest pharmaceutical giants, possessing a colossal financial base. Its book value is derived from its global network of manufacturing plants and research centers, as well as its patent portfolio, which has been significantly strengthened by the success of its COVID-19 vaccine.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Pfizer Inc.
Pfizer Inc. is one of the largest pharmaceutical giants. Its stock premium has grown significantly during the pandemic thanks to the success of its vaccine. The chart shows how the market is revaluing the company, weighing its current blockbusters against its ability to find new sources of growth.
Market to book capitalization ratio in a market segment - Pharma holding
Pfizer is one of the world's largest pharmaceutical giants, whose valuation soared during the pandemic thanks to its COVID-19 vaccine. The market is now assessing its ability to find new sources of growth. This chart shows how investor expectations for future blockbusters and R&D impact its market value relative to its vast manufacturing assets.
Market to book capitalization ratio for the market as a whole
Pfizer is one of the world's largest pharmaceutical companies, gaining significant attention for its COVID-19 vaccine. Compared to average market valuations shown in the chart, its valuation reflects both revenue from existing blockbusters and challenges related to patent expirations and the need for new discoveries.
Debts of the company, segment and market as a whole
PFE - Company debts Pfizer Inc.
For Pfizer, its debt history in recent years is closely tied to its transformation. The company leveraged its financial strength, boosted by the success of its COVID-19 vaccine, to make major acquisitions, such as the purchase of Seagen, financing them in part with debt. This chart shows how the company is using capital to strengthen its position in oncology and other key areas.
Market segment debts - Pharma holding
Pfizer is one of the global pharmaceutical giants whose profile has changed significantly following the success of its COVID-19 vaccine. The company's massive cash flows allowed it to invest heavily in R&D and make major acquisitions (like Seagen) to strengthen its oncology business. This chart shows how the company is leveraging its financial strength for future growth.
Market debt in general
Pfizer is one of the global pharmaceutical giants, whose success was fueled by the development of a COVID-19 vaccine. The company uses its massive cash flows to invest in new drugs and acquisitions. This total debt chart allows us to assess how Pfizer is managing its capital following its unprecedented success and how its financial strategy compares to the market.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical giants, whose prestige has been boosted by the development of a COVID-19 vaccine. This chart shows how the company uses its massive cash flow and leverage. Debt is often used to finance mega-acquisitions aimed at expanding its pipeline with new blockbusters.
Market segment debt to market segment book capitalization - Pharma holding
Pfizer, one of the global pharmaceutical giants, has received significant attention for its COVID-19 vaccine. The company is actively using its capital for acquisitions and R&D. This chart shows how its leverage compares to the financial health of the pharmaceutical industry as a whole, reflecting its commitment to expanding its portfolio with new drugs.
Debt to book value of all companies in the market
Pfizer, one of the world's largest pharmaceutical giants, uses its financial resources for acquisitions and development. This chart compares its debt policy with the overall market. It shows that the company's debt burden is moderate compared to the average debt level across the economy, reflecting its scale and stability.
P/E of the company, segment and market as a whole
P/E - Pfizer Inc.
This chart for Pfizer, one of the world's largest pharmaceutical giants, vividly illustrates the impact of blockbusters on valuation. Its P/E can fluctuate dramatically depending on the success or failure of key products, as was the case with the COVID-19 vaccine. The dynamics show how the market assesses the company's ability to replace revenue after patents expire.
P/E of the market segment - Pharma holding
Pfizer Inc. is one of the global pharmaceutical giants that has gained attention thanks to its COVID-19 vaccine. The company is using its revenue to invest in new developments. This chart shows the average valuation for the pharmaceutical industry, which helps understand how the market views Pfizer's ability to create new blockbusters after the pandemic.
P/E of the market as a whole
Pfizer is one of the global pharmaceutical giants, whose name became a household name after developing a COVID-19 vaccine. Its valuation now depends on its ability to offset declining revenue from COVID-19 products through new developments and successful acquisitions. This overall sentiment graph is less important for Pfizer than news about clinical trials and new drug approvals.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Pfizer Inc.
Pfizer, one of the global pharmaceutical giants, has received enormous attention thanks to its COVID-19 vaccine. This chart now reflects investor expectations for the company's future post-pandemic. The valuation depends on its ability to offset the decline in revenue from COVID-19 products through growth in its remaining portfolio and the launch of new successful drugs.
%20P%2FE%20Pfizer%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Pfizer-Inc.&v=1772540697728 "Chart of the company's future (projected) P/E Pfizer Inc.")
Future (projected) P/E of the market segment - Pharma holding
Pfizer, one of the world's largest pharmaceutical giants, gained immense recognition thanks to its COVID-19 vaccine and treatment. The company now faces the challenge of finding new growth drivers. This chart shows the market's assessment of its post-COVID future. It compares its profit forecasts with the sector, showing how much investors believe in its new developments.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-holding&v=1772540697791 "Future (projected) P/E graph of the market segment - Pharma holding")
Future (projected) P/E of the market as a whole
Pfizer, one of the global pharmaceutical giants, has once again found itself in the spotlight thanks to its vaccines and other treatments. The company's future depends on its ability to expand its portfolio with new blockbusters. The overall market backdrop, as shown by this chart, influences the valuation of the entire sector, but for Pfizer, the key question remains the success of its R&D pipeline.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772540697824 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Pfizer Inc.
Pfizer Inc. is one of the world's leading pharmaceutical companies. Its profits depend on sales of a broad portfolio of drugs and vaccines. This graph often reflects blockbuster cycles: explosive growth from new successful products (such as the COVID-19 vaccine) followed by a search for new revenue streams after patents expire or demand declines.
Profit of companies in the market segment - Pharma holding
Pfizer is one of the world's largest pharmaceutical giants, becoming a household name during the pandemic thanks to its COVID-19 vaccine development. The company has a broad portfolio of drugs and vaccines. Its ability to develop and market new blockbusters is a key factor influencing the profitability and direction of the entire pharmaceutical industry.
Overall market profit
Pfizer is one of the world's leading biopharmaceutical companies, developing and producing a wide range of medicines and vaccines. Its global reach and successful blockbusters, including the COVID-19 vaccine, make it a key player in the global healthcare system. Pfizer's financial results reflect both current treatment needs and future directions in medical advancement.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Pfizer Inc.
Pfizer, one of the global pharmaceutical giants, has received significant attention for its COVID-19 vaccine. This chart reflects analysts' post-pandemic revenue expectations, which now hinge on sales of the rest of the company's drug portfolio, particularly in oncology, and the success of new developments.
%20profit%20of%20the%20company%20Pfizer%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Pfizer-Inc.&v=1772540698143 "Graph of future (projected) profit of the company Pfizer Inc.")
Future (predicted) profit of companies in the market segment - Pharma holding
Following the success of its COVID-19 vaccine, Pfizer Inc. continues to be one of the world's leading pharmaceutical giants with a broad portfolio of drugs. This chart reflects profitability forecasts for the entire pharmaceutical industry. It allows one to compare Pfizer's future growth drivers with analysts' overall expectations for the healthcare sector.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-holding&v=1772540698187 "Graph of future (predicted) profits of companies in a market segment - Pharma holding")
Future (predicted) profit of the market as a whole
Pharmaceutical giant Pfizer's profit forecast hinges on the success of its product portfolio following declining revenue from COVID-19 vaccines and treatments. This chart reflects expectations for sales of oncology and immunology drugs, as well as the company's ability to bring new blockbusters from its extensive pipeline to market.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772540698256 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Pfizer Inc.
Pfizer, one of the global pharmaceutical giants, has generated massive revenue from its COVID-19 vaccine and treatment. This chart shows how investors view its sales post-pandemic. The market's multiple reflects whether the company believes it can offset the decline in revenue from COVID-19 treatments with other products.
P/S market segment - Pharma holding
Pfizer is one of the world's largest pharmaceutical companies, widely known for developing one of the first COVID-19 vaccines. The company has a diversified portfolio of drugs. This chart shows the average revenue estimate in the pharmaceutical industry. It helps assess how the market views Pfizer's prospects after the pandemic boom.
P/S of the market as a whole
Pfizer is one of the global pharmaceutical giants whose revenues received a huge boost from sales of its COVID-19 vaccine and treatment. The company now faces the challenge of offsetting these declines. This chart, which displays Pfizer's average revenue estimates, helps understand how the market views its ability to generate growth post-pandemic through other drugs.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Pfizer Inc.
Pfizer is one of the global pharmaceutical giants whose revenues soared during the pandemic thanks to its COVID-19 vaccine and treatment. The company now faces the challenge of sustaining growth after demand for these products declines. This chart shows how investors assess future revenues from the rest of its drug portfolio and the potential of new developments.
%20P%2FS%20Pfizer%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Pfizer-Inc.&v=1772540698544 "The graph of the company's future (projected) P/S Pfizer Inc.")
Future (projected) P/S of the market segment - Pharma holding
Pfizer is one of the global pharmaceutical giants, widely known for its COVID-19 vaccine developed with BioNTech. This chart shows how the market is assessing the company's future post-pandemic. Do investors believe Pfizer will be able to use its revenue to develop new blockbusters, or are its valuations reflecting the decline in COVID-19 sales?
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20holding&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-holding&v=1772540698573 "Future (projected) P/S market segment graph - Pharma holding")
Future (projected) P/S of the market as a whole
Pfizer is one of the global pharmaceutical giants, widely known for its COVID-19 vaccine. The company is now focusing on oncology and other key therapeutic areas. The success of its new drugs in replacing lost vaccine revenue is important for the entire sector and influences overall sentiment, as reflected in this chart.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772540698808 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical companies, with a portfolio that includes both innovative drugs and established medicines. The company's revenue is heavily dependent on the success of its blockbusters and its ability to bring new products to market. This chart shows the commercial performance of its extensive portfolio.
Sales of companies in the market segment - Pharma holding
Pfizer is a global pharmaceutical giant, a household name thanks to the development of one of the first COVID-19 vaccines. The company has a broad portfolio of drugs across various therapeutic areas. This chart shows overall pharmaceutical sales, demonstrating the vast market in which Pfizer competes and innovates.
Overall market sales
Pfizer is a global pharmaceutical giant, developing a wide range of drugs and vaccines. The company gained widespread recognition for its COVID-19 vaccine. This overall economic activity chart is important for Pfizer because it impacts the solvency of healthcare systems worldwide and their ability to purchase innovative drugs.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Pfizer Inc.
Pfizer is one of the world's pharmaceutical giants. Following the massive revenues from its COVID-19 vaccine, the company's future sales depend on the success of its core businesses, including drugs in oncology, cardiology, and rare diseases. This chart shows analysts' sales forecasts for its core product portfolio and the potential for new developments.
%20sales%20of%20the%20company%20Pfizer%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Pfizer-Inc.&v=1772540699021 "Schedule of future (projected) sales of the company Pfizer Inc.")
Future (projected) sales of companies in the market segment - Pharma holding
Pfizer Inc. is one of the world's largest pharmaceutical companies, having developed a wide range of drugs and vaccines, including a COVID-19 vaccine. This chart reflects projected revenues for the entire pharmaceutical sector. It helps assess overall expectations for healthcare spending growth, providing context for evaluating Pfizer's drug portfolio and research programs.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-holding&v=1772540699039 "Schedule of future (projected) sales of companies in the market segment - Pharma holding")
Future (projected) sales of the market as a whole
Pfizer is a global pharmaceutical giant with a diversified portfolio of drugs and vaccines. The company's success depends on the launch of new blockbuster drugs. Although drug demand is less cyclical, the overall economic situation, reflected in this chart, affects the ability of healthcare systems worldwide to afford the innovative and often expensive treatments offered by Pfizer.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772540699104 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical giants, whose name became a household name during the pandemic thanks to its COVID-19 vaccine. This chart clearly demonstrates the financial impact of a single, highly successful drug. The trend shows both the pandemic-related peak and the subsequent normalization of financial flows.
Market segment marginality - Pharma holding
Pfizer is a global pharmaceutical company that gained widespread recognition for its COVID-19 vaccine and treatment. Its strategy includes both internal development and acquisition of promising biotech companies to expand its portfolio. This metric reflects how the success of blockbusters and the effectiveness of R&D impact the profitability of one of the pharmaceutical industry's giants.
Market marginality as a whole
Pfizer is one of the world's leading pharmaceutical giants, whose COVID-19 vaccine became a household name during the pandemic. This chart shows average profitability. It demonstrates how a scientific breakthrough can radically change a company's financial position, but also highlights the need to continually expand its portfolio with new drugs.
Employees in the company, segment and market as a whole
Number of employees in the company Pfizer Inc.
Pfizer is one of the global pharmaceutical giants, whose COVID-19 vaccine became a household name during the pandemic. This chart shows the massive team behind research, production, and global distribution. Drastic changes in headcount could be due to major mergers or the end of exclusivity on blockbusters.
Share of the company's employees Pfizer Inc. within the market segment - Pharma holding
This chart demonstrates Pfizer's scale as one of the world's largest pharmaceutical giants. Its vast share of employees in the sector reflects its global reach and broad drug portfolio. This human capital was particularly evident during the pandemic, when the company was able to rapidly develop and produce hundreds of millions of doses of a COVID-19 vaccine.
Number of employees in the market segment - Pharma holding
Pfizer is one of the global pharmaceutical giants, whose name became a household name after developing one of the first COVID-19 vaccines. Large-scale research, production, and global marketing require a huge team of specialists. This chart illustrates the size of the pharmaceutical sector, where Pfizer is one of the most influential players and employers.
Number of employees in the market as a whole
Pfizer is one of the world's largest pharmaceutical giants, a household name after the success of its COVID-19 vaccine (Comirnaty). The company is also strong in oncology and producing blockbuster drugs like Eliquis. This chart reflects the economic base that funds healthcare. Stable employment (and tax revenues) allows governments and insurance companies to pay for their mass vaccines and expensive drugs.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Pfizer Inc. (PFE)
Pfizer is one of the world's pharmaceutical giants. The success of its COVID-19 vaccine has dramatically increased its market capitalization. This chart reflects the company's ability to quickly develop and market blockbusters, where the intellectual capital of its scientific team generates tens of billions of dollars.
%20of%20the%20company%20Pfizer%20Inc.%20(PFE)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Pfizer-Inc.-PFE&v=1772540699464 "Chart of market capitalization per employee (in thousands of dollars) of the company Pfizer Inc. (PFE)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma holding
Pfizer is a global pharmaceutical giant whose reputation soared on the success of its COVID-19 vaccine. The market is now assessing its ability to replace that revenue with new blockbusters. This chart shows the market value per employee, reflecting the company's enormous scale and (current) market skepticism about its R&D pipeline.
%20by%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-holding&v=1772540699537 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma holding")
Market capitalization per employee (in thousands of dollars) for the overall market
Pfizer is one of the global pharmaceutical giants, whose success was fueled by the development of a COVID-19 vaccine. This chart shows how the market values its ability to rapidly innovate and bring blockbusters to market. The high valuation per employee reflects the enormous value of intellectual property generated by its research teams.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772540699591 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Pfizer Inc. (PFE)
Pfizer is one of the world's largest pharmaceutical giants, whose name made headlines with its COVID-19 vaccine (developed with BioNTech). This chart shows how a single global health challenge can transform a company's finances. The vaccine and Paxlovid generated colossal profits, dramatically increasing the company's return on investment.
%20Chart%20Pfizer%20Inc.%20(PFE)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Pfizer-Inc.-PFE&v=1772540699721 "Company Profit Per Employee (in thousands of dollars) Chart Pfizer Inc. (PFE)")
Profit per employee (in thousands of dollars) in the market segment - Pharma holding
Pfizer is one of the world's largest pharmaceutical giants. This chart shows the average for the entire pharmaceutical industry. This sector thrives on R&D and patents. The average return on staff is high here, as a single successful drug patent (like the Covid vaccine) can generate billions, covering all the costs of staffing scientists.
%20in%20the%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-holding&v=1772540699778 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma holding")
Profit per employee (in thousands of dollars) for the market as a whole
Pfizer is a global pharmaceutical giant, widely known for its COVID-19 vaccine. Like other industry leaders, the company is focusing on developing and launching new blockbuster drugs. This chart shows how successful clinical trials and global marketing impact the financial returns of each employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772540699801 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Pfizer Inc. (PFE)
Pfizer is one of the world's largest pharmaceutical giants, whose vaccine became a household name during the pandemic. This chart shows how extensive research and global reach generate colossal revenue. The success of a single blockbuster can dramatically boost the performance of the entire company.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Pfizer-Inc.-PFE&v=1772540699905 "Sales chart per company employee Pfizer Inc. (PFE)")
Sales per employee in the market segment - Pharma holding
Pfizer is one of the world's largest pharmaceutical giants, gaining significant attention thanks to its COVID-19 vaccine. This chart shows the average revenue per employee in the segment. It helps assess how productive the company is after its reorganization and how it is using its vaccine revenue compared to other Big Pharma players.
Sales per employee for the market as a whole
Pfizer is a pillar of global Big Pharma. The company became world-famous for its COVID-19 vaccine (developed with BioNTech). This success is a shining example of how the pharmaceutical business works: years of R&D can lead to the creation of a global blockbuster that generates tens of billions in revenue, even with the same team of researchers and marketers.
Short shares by company, segment and market as a whole
Shares shorted by company Pfizer Inc. (PFE)
Pfizer is one of the world's largest pharmaceutical giants. The bearish sentiment seen in this chart reflects the sharp decline in demand for COVID-19 vaccines and treatments (Comirnaty, Paxlovid), which generated tens of billions of dollars. Bears doubt Pfizer will be able to quickly offset this "COVID cliff" with new products.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Pfizer-Inc.-PFE&v=1772540700126 "Short Shares Chart for the Company Pfizer Inc. (PFE)")
Shares shorted by market segment - Pharma holding
Pfizer is one of the global pharmaceutical giants, whose name has become a household name thanks to its COVID-19 vaccine. The company is seeking new growth opportunities after the pandemic. This chart shows the general sentiment towards the sector. It reflects investor concerns about a sharp decline in revenue from COVID-19 products and general pressure on drug prices from regulators.
Shares shorted by the overall market
Pfizer is one of the world's largest pharmaceutical giants, creating vaccines and life-saving medications. During periods when this chart rises, indicating a buildup of general pessimism in the market, investors often seek protection. The healthcare sector, and Pfizer in particular, is traditionally considered a "safe haven," less dependent on economic cycles.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Pfizer Inc. (PFE)
Pfizer is one of the largest pharmaceutical giants. This chart shows how quickly and dramatically the price changes. After the COVID-19 hype, which pushed the indicator into overbought territory (>70), a "hangover" has set in. A drop into oversold territory (below 30) often reflects market pessimism, which doesn't believe the R&D portfolio (oncology) can quickly replace lost vaccine revenue.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Pfizer-Inc.-PFE&v=1772540700298 "RSI 14 indicator chart for the company's stock Pfizer Inc. (PFE)")
RSI 14 Market Segment - Pharma holding
Pfizer (PFE) is a giant pharmaceutical corporation whose fate following the success of its COVID-19 vaccine is causing much debate. This metric measures the overall momentum of the Big Pharma sector. It helps us understand whether PFE shares are rising (or falling) due to unique developments in oncology or simply following the general trend of the industry, which may be overheated by expectations of new blockbusters.
RSI 14 for the overall market
Pfizer is more than just a COVID vaccine; it's a global pharmaceutical giant with a century-long history. While this chart shows the market swinging from euphoria to panic, Pfizer's real business—developing drugs for everything from cancer to rare diseases—requires billions of dollars in investment and decades of development, regardless of trader sentiment.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast PFE (Pfizer Inc.)
This chart shows how analysts are valuing Pfizer following the massive success of its COVID-19 vaccine. Their target prices now reflect the "post-COVID cliff" in revenue and expectations for its new oncology portfolio (following the acquisition of Seagen). The consensus forecast is essentially a bet on whether the company's new R&D pipeline will be able to offset the dwindling revenue from Comirnaty.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-PFE-Pfizer-Inc.&v=1772540700452 "A chart showing analyst consensus forecasts for the expected stock price. PFE (Pfizer Inc.)")
The difference between the consensus estimate and the actual stock price PFE (Pfizer Inc.)
Pharmaceutical giant Pfizer is undergoing a transformation following a boom in vaccine revenue. The company is actively investing in oncology and rare diseases to offset expiring patents. This chart displays analysts' opinions on whether the new drug portfolio can drive growth. It shows the difference between the consensus price and the current market valuation.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-PFE-Pfizer-Inc.&v=1772540700473 "A chart showing the difference between the consensus forecast and the actual stock price. PFE (Pfizer Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma holding
Following its triumph with the COVID vaccine, Pfizer is refocusing on its core R&D pipeline, particularly in oncology. The company's future depends on the success of its new drugs. This chart shows the overall sentiment of analysts across the pharmaceutical sector. It reflects whether industry experts see new blockbusters or anticipate a decline after the pandemic.
Analysts' consensus forecast for the overall market share price
Pfizer is a pillar of the global pharmaceutical industry. Although demand for its medications is relatively stable, overall market sentiment, as seen in this chart, influences the company. Market optimism facilitates funding for M&A and expensive R&D projects, which fuel growth for a giant like Pfizer.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Pfizer Inc.
Pfizer is a global pharmaceutical giant whose name became a household name after the success of its COVID-19 vaccine. The company is now using these revenues to reboot its operations, aggressively investing in oncology (through the acquisition of Seagen) and other promising areas. This chart reflects the complex transition: it weighs the decline in COVID-19 revenue against market expectations for its new, updated pipeline.
AKIMA Market Segment Index - Pharma holding
Pfizer is a global pharmaceutical giant known for its blockbusters (like Comirnaty) and recent focus on oncology through major acquisitions. This comprehensive index evaluates companies based on R&D and efficiency. The chart shows the average value for the segment. This benchmark helps understand how Pfizer's R&D pipeline allows it to outperform the average pharma company on this aggregate metric.
The AKIM Index for the overall market
Pfizer is a global pharmaceutical giant whose strategy is built on blockbuster development and major acquisitions. Although the healthcare sector is considered defensive, Pfizer's success depends on R&D and market perception of its portfolio. This chart, showing the market average, provides macro context. It helps assess how investors view Pfizer against the backdrop of the overall economic environment and risk appetite.
